Molecular hydrogen modulates brain glutamate/GABA-glutamine cycle in overweight humans.

"Conflict of interest SMO co-owns patent “Agent for Inhibiting Deterioration of Recognition Function Comprising Hydrogen Gas” at the Japan Patent Office (2016-163322), and has received research support related to molecular hydrogen during the past 36 months from the Serbian Ministry of Education, Science, and Technological Development, the Provincial Secretariat for Higher Education and Scientific Research, Natural Health Products Inc, EvoDrop, and SeaCret Direct. SMO is the founder of Centram, a biotechnology startup developing and commercializing innovative nutraceuticals that can support and rejuvenate energy metabolism, the gut-brain-muscle axis, and immunity across various health domains. SMO does not own stocks and shares in any organization. DK, JO, and NT declare no conflict of interest."

"SMO co-owns patent “Agent for Inhibiting Deterioration of Recognition Function Comprising Hydrogen Gas” at the Japan Patent Office (2016-163322), and has received research support related to molecular hydrogen during the past 36 months from the Serbian Ministry of Education, Science, and Technological Development, the Provincial Secretariat for Higher Education and Scientific Research, Natural Health Products Inc, EvoDrop, and SeaCret Direct. SMO is the founder of Centram, a biotechnology startup developing and commercializing innovative nutraceuticals that can support and rejuvenate energy metabolism, the gut-brain-muscle axis, and immunity across various health domains. SMO does not own stocks and shares in any organization. DK, JO, and NT declare no conflict of interest."